- Home
- WASH vs PHAR Comparison
WASH vs PHAR Comparison
Compare WASH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WASH | PHAR |
|---|---|---|
| Founded | 1800 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 544.2M | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WASH | PHAR |
|---|---|---|
| Price | $30.62 | $17.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $30.25 | $30.00 |
| AVG Volume (30 Days) | ★ 97.3K | 21.0K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | ★ 7.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $117,341,000.00 | ★ $362,274,000.00 |
| Revenue This Year | $57.78 | $24.80 |
| Revenue Next Year | $8.69 | $6.84 |
| P/E Ratio | ★ N/A | $3,084.39 |
| Revenue Growth | N/A | ★ 26.78 |
| 52 Week Low | $24.95 | $7.50 |
| 52 Week High | $36.98 | $18.12 |
Technical Indicators
Market Signals| Indicator | WASH | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 71.60 | 60.83 |
| Support Level | $29.05 | $15.76 |
| Resistance Level | $31.03 | $17.35 |
| Average True Range (ATR) | 0.57 | 0.77 |
| MACD | 0.26 | 0.02 |
| Stochastic Oscillator | 93.44 | 89.41 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.